trial

Diabetes Screening, Risk Management and Disease Management in a High-Risk Mental Health Population

NCTId NCT00253240
as of 2026-07-01
Add to landscapeMonitor thisAsk about this
at a glance
Phase — · Completed
Enrollment 75 (actual)
Sponsored by London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's
Synthesized from structured facts only — each point cited above.

Design & status

Phase
—
Status
Completed
Enrollment
75 (actual)
Study type
Observational
Allocation
—
Model
—
Masking
—
Start
2004-09
Primary completion
—
Eligibility
ALL · 18 Years · 75 Years

Interventions & indications

Drugs
ScreeningManagement

Sponsors

London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph'sLead Sponsor
Ontario Ministry of Health and Long Term CareCollaborator
Western Ontario Therapeutic Community Hostel (WOTCH)Collaborator
Canadian Mental Health AssociationCollaborator
London Intercommunity Health Centre (LIHC)Collaborator

Investigators

2
David RS Haslam, MSc MD FRCPCPrincipal Investigator
Stewart B Harris, MD MPH CCFP FACPMPrincipal Investigator

Sites

1 total
London, Canada

Facts & assertions

3 sourced
Enrollment
75
Phase
NA
Status
COMPLETED
relationships
The graph out of here
drug
Screening
drug
Management
drug
lead_sponsor
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's
company
collaborator
Ontario Ministry of Health and Long Term Care
company
Western Ontario Therapeutic Community Hostel (WOTCH)
company
indication
Psychotic Disorders
indication
Diabetes Mellitus
indication
Diabetes Mellitus
indication
investigator
David RS Haslam, MSc MD FRCPC
person
Stewart B Harris, MD MPH CCFP FACPM
person